Alphaxrt Pty Ltd

Status: Registered
Current name since: 2014-03-05
Name in the ASICs register: Alphaxrt Pty Ltd
Australian Company Number: 101297545
Australian Business Number: 88101297545
Registration date: 2002-07-09
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Alphaxrt Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2002-07-09 and was issued with the 101297545 ACN. Its Australian Business Number is 88101297545. Since 2011-09-06, the company is headquartered in NSW, post code 2009. The previous headquarters were located in NSW 1430 (from 2007-11-08 to 2011-09-06), NSW 1430 (from 2002-07-09 to 2007-11-08). Alphaxrt Pty Ltd was registered for the GST on 2002-07-09. In total the company used 0 trading names. The above data comes from the ABN database which was updated on 2014-03-06. We found 0 trademarks that mention this company.


Details for ABN 88101297545

Type: Australian Private Company

ABN Status

Status From To
Active 2002-07-09 current

Main Name

Name From To
Alphaxrt Pty Ltd 2014-03-05 current
Cms Alphatech Pty Limited 2002-07-09 2014-03-05

Main Location

Location From To
NSW 2009 2011-09-06 current
NSW 1430 2007-11-08 2011-09-06
NSW 1430 2002-07-09 2007-11-08

Goods & Services Tax (GST)

Status From To
Registered 2002-07-09 current


Find company

NSW 2009 Location

2016 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (, and, ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.